| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/01/2023 | 19.05% | Raymond James | $46 → $43 | Maintains | Outperform |
| 07/13/2023 | 24.58% | Raymond James | $47 → $45 | Maintains | Outperform |
| 05/03/2023 | 30.12% | Raymond James | $48 → $47 | Maintains | Outperform |
| 04/20/2023 | 27.35% | Piper Sandler | $47 → $46 | Maintains | Overweight |
| 04/14/2023 | 32.89% | Raymond James | $40 → $48 | Maintains | Outperform |
| 02/08/2023 | 46.73% | Bernstein | $48 → $53 | Maintains | Outperform |
| 02/08/2023 | 10.74% | Raymond James | $39 → $40 | Maintains | Outperform |
| 01/10/2023 | 2.44% | Wells Fargo | $36 → $37 | Maintains | Equal-Weight |
| 12/19/2022 | 7.97% | Piper Sandler | $40 → $39 | Maintains | Overweight |
| 11/11/2022 | 10.74% | Piper Sandler | $37 → $40 | Maintains | Overweight |
| 11/07/2022 | -0.33% | Wells Fargo | $31 → $36 | Upgrades | Underweight → Equal-Weight |
| 10/13/2022 | — | Scotiabank | Downgrades | Sector Outperform → Sector Perform | |
| 09/12/2022 | 30.12% | Piper Sandler | $44 → $47 | Maintains | Overweight |
| 08/03/2022 | -19.71% | Wells Fargo | $31 → $29 | Maintains | Underweight |
| 07/19/2022 | 21.82% | Piper Sandler | $42 → $44 | Maintains | Overweight |
| 05/04/2022 | -14.17% | Wells Fargo | $29 → $31 | Maintains | Underweight |
| 04/18/2022 | 7.97% | Raymond James | $37 → $39 | Maintains | Outperform |
| 03/23/2022 | — | Morgan Stanley | Upgrades | Equal-Weight → Overweight | |
| 03/11/2022 | -19.71% | Wells Fargo | $28 → $29 | Maintains | Underweight |
| 03/08/2022 | — | B of A Securities | Upgrades | Underperform → Neutral | |
| 03/01/2022 | 16.28% | MKM Partners | $46 → $42 | Maintains | Buy |
| 02/09/2022 | 2.44% | Raymond James | $36 → $37 | Maintains | Outperform |
| 01/18/2022 | -0.33% | Raymond James | $33 → $36 | Maintains | Outperform |
| 01/07/2022 | — | Exane BNP Paribas | Upgrades | Neutral → Outperform | |
| 01/05/2022 | — | Wells Fargo | Downgrades | Overweight → Underweight | |
| 01/04/2022 | -0.33% | Evercore ISI Group | → $36 | Upgrades | In-Line → Outperform |
| 10/25/2021 | -14.17% | TD Securities | → $31 | Initiates Coverage On | → Hold |
| 10/20/2021 | -8.64% | Raymond James | $30 → $33 | Maintains | Outperform |
| 10/15/2021 | — | Berenberg | Upgrades | Hold → Buy | |
| 08/06/2021 | — | Morgan Stanley | Upgrades | Underweight → Equal-Weight | |
| 06/30/2021 | -11.41% | Wells Fargo | $31 → $32 | Maintains | Overweight |
| 06/24/2021 | — | HSBC | Downgrades | Buy → Hold | |
| 04/16/2021 | — | HSBC | Upgrades | Hold → Buy | |
| 03/31/2021 | — | Morgan Stanley | Downgrades | Equal-Weight → Underweight | |
| 03/17/2021 | -19.71% | Raymond James | $27 → $29 | Maintains | Outperform |
| 02/03/2021 | -25.25% | Raymond James | $30 → $27 | Maintains | Outperform |
| 01/27/2021 | -14.17% | MKM Partners | → $31 | Initiates Coverage On | → Buy |
| 01/12/2021 | -25.25% | Mizuho | → $27 | Initiates Coverage On | → Neutral |
| 11/03/2020 | — | Morgan Stanley | Upgrades | Underweight → Equal-Weight | |
| 09/24/2020 | -36.32% | Scotiabank | → $23 | Initiates Coverage On | → Sector Perform |
| 08/17/2020 | -14.17% | Piper Sandler | $28 → $31 | Upgrades | Neutral → Overweight |
| 08/05/2020 | — | Evercore ISI Group | Downgrades | Outperform → In-Line | |
| 07/20/2020 | -22.48% | Raymond James | $26 → $28 | Maintains | Outperform |
| 07/16/2020 | -25.53% | Jefferies | → $26.9 | Upgrades | Hold → Buy |
| 04/28/2020 | -28.02% | CFRA | $42 → $26 | Downgrades | Buy → Hold |
| 04/03/2020 | -14.17% | Wells Fargo | $27 → $31 | Maintains | Overweight |
| 03/20/2020 | -25.25% | Wells Fargo | $46 → $27 | Maintains | Overweight |
| 03/12/2020 | — | Citigroup | Downgrades | Buy → Neutral | |
| 10/31/2019 | — | Argus Research | Downgrades | Buy → Hold | |
| 08/21/2019 | 46.73% | BMO Capital | → $53 | Initiates Coverage On | → Outperform |
| 07/31/2019 | 34.55% | Jefferies | $46.3 → $48.6 | Upgrades | Hold → Buy |
| 07/10/2019 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
| 04/16/2019 | — | RBC Capital | Downgrades | Top Pick → Outperform | |
| 12/18/2018 | 13.51% | Wells Fargo | → $41 | Initiates Coverage On | → Market Perform |
| 11/20/2018 | — | Raymond James | Upgrades | Market Perform → Outperform |
What is the target price for BP (BP)?
The latest price target for BP (NYSE: BP) was reported by Raymond James on November 1, 2023. The analyst firm set a price target for $43.00 expecting BP to rise to within 12 months (a possible 19.05% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for BP (BP)?
The latest analyst rating for BP (NYSE: BP) was provided by Raymond James, and BP maintained their outperform rating.
When is the next analyst rating going to be posted or updated for BP (BP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BP, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BP was filed on November 1, 2023 so you should expect the next rating to be made available sometime around November 1, 2024.
Is the Analyst Rating BP (BP) correct?
While ratings are subjective and will change, the latest BP (BP) rating was a maintained with a price target of $46.00 to $43.00. The current price BP (BP) is trading at is $36.12, which is out of the analyst's predicted range.